138 related articles for article (PubMed ID: 33044742)
101. Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma.
Thurner L; Hartmann S; Fadle N; Regitz E; Kemele M; Kim YJ; Bohle RM; Nimmesgern A; von Müller L; Kempf VAJ; Weniger MA; Neumann F; Schneider N; Vornanen M; Sundström C; de Leval L; Engert A; Eichenauer DA; Küppers R; Preuss KD; Hansmann ML; Pfreundschuh M
Nat Commun; 2020 May; 11(1):2465. PubMed ID: 32424289
[TBL] [Abstract][Full Text] [Related]
102. A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma.
Kiil K; Bein J; Schuhmacher B; Thurner L; Schneider M; Hansmann ML; Hartmann S
Virchows Arch; 2018 Dec; 473(6):759-764. PubMed ID: 30259184
[TBL] [Abstract][Full Text] [Related]
103. Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse.
Bein J; Thurner L; Hansmann ML; Hartmann S
Am J Hematol; 2020 Dec; 95(12):1495-1502. PubMed ID: 32815561
[TBL] [Abstract][Full Text] [Related]
104. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
[TBL] [Abstract][Full Text] [Related]
105. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
[TBL] [Abstract][Full Text] [Related]
106. Lymphocyte predominant Hodgkin lymphoma, antigen-driven after all?
Poppema S
J Pathol; 2021 Jan; 253(1):1-10. PubMed ID: 33044742
[TBL] [Abstract][Full Text] [Related]
107. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
[TBL] [Abstract][Full Text] [Related]
108. Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma.
Hartmann S; Eichenauer DA
Pathology; 2020 Jan; 52(1):142-153. PubMed ID: 31785822
[TBL] [Abstract][Full Text] [Related]
109. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].
Gorde-Grosjean S; Guimard G; Lambilliotte A; Coulomb-Lhermine A; Montravers F; Landman-Parker J
Bull Cancer; 2014 Sep; 101(9):881-90. PubMed ID: 25296072
[TBL] [Abstract][Full Text] [Related]
110. Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma.
Rahemtullah A; Harris NL; Dorn ME; Preffer FI; Hasserjian RP
Leuk Lymphoma; 2008 Oct; 49(10):1870-8. PubMed ID: 18949610
[TBL] [Abstract][Full Text] [Related]
111. Modern management of lymphocyte-predominant Hodgkin lymphoma.
Xing KH; Savage KJ
Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
[TBL] [Abstract][Full Text] [Related]
112. Nodular lymphocyte-predominant Hodgkin lymphoma.
Savage KJ; Mottok A; Fanale M
Semin Hematol; 2016 Jul; 53(3):190-202. PubMed ID: 27496311
[TBL] [Abstract][Full Text] [Related]
113. Molecular aspects of Moraxella catarrhalis pathogenesis.
de Vries SP; Bootsma HJ; Hays JP; Hermans PW
Microbiol Mol Biol Rev; 2009 Sep; 73(3):389-406, Table of Contents. PubMed ID: 19721084
[TBL] [Abstract][Full Text] [Related]
114. Pitfalls in the Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma: Variant Patterns, Borderlines and Mimics.
Younes S; Rojansky RB; Menke JR; Gratzinger D; Natkunam Y
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208705
[TBL] [Abstract][Full Text] [Related]
115.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
116.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
117.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
118.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
119.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
